CJMB - הכנסה תפעולית לפני ניכוי פחת callanjmb.com

Callan JMB Inc (CJMB) maintains niche leadership in clinics through direct B2B sales. The monetary value of EBITDA confirms this resilience, with 0.00 serving as the current metric level. Growth is driven by the development of minimally invasive systems and 3D implant modeling, as well as the implementation of new endoscopes and imaging technology patents, which enhance surgical precision in the US.

This indicator assesses the daily liquidity of the core business, capturing real cash flow from operating activities to analyze creditworthiness and identify hidden decay in cash flows. In the case of Callan JMB Inc. (CJMB), the company's operating profit reflects the monetization efficiency of its closed-loop surgical service and training, allowing investors to evaluate the sustainability of revenues derived from the operation of proprietary equipment.